NEXIEN BIOPHARMA, INC. — Revenue by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/b648c083-8c68-4f2d-a7ad-8e113fa3681a/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2017 | $0 | 2016-07-01 – 2017-06-30 | evidence 0001295345-17-000219 |
| FY 2016 | $0 | 2015-07-01 – 2016-06-30 | evidence 0001295345-16-000689 |
| FY 2015 | $0 | 2014-07-01 – 2015-06-30 | evidence 0001295345-15-000260 |
| FY 2014 | $0 | 2013-07-01 – 2014-06-30 | evidence 0001295345-15-000260 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
NEXIEN BIOPHARMA, INC. — all facts · Net Income · Operating Income